Promising New Therapy for MS & Immune System Disorders
The low dose naltrexone protocol has a long history of success treating autoimmune diseases. Over 20 years ago, naltrexone was approved by the FDA to treat addiction, at much higher doses. But in 1982 Dr. Ian Zagon and other researchers at Penn State University discovered its ability to normalize a dysfunctional immune system, when used in very low doses. Bernard Bihari, MD, a Harvard trained neurologist in New York City, observed positive clinical results using LDN for HIV, MS and other immune system disorders. His observations led to years of devoted work with patients, treating every kind of immune disease -- including HIV/AIDS – with extremely positive results, and virtually no side effects.
According to Dr. Bihari’s friend and colleague, David Gluck, MD, who also works tirelessly to get the word out about LDN: ““Low Dose Naltrexone may well be the most important therapeutic breakthrough in over fifty years. It provides a safe and inexpensive method of medical treatment by mobilizing the natural defenses of one's own immune system.”
Doctors throughout the US, UK, Canada, Italy, Israel, Australia and Nigeria prescribe LDN for their patients.
Monday, October 19, 2009
Lister Hill Auditorium in the National Library of Science Building
National Institutes of Health
Bethesda, Maryland
LDN treatment has helped over 50,000 people with Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s Disease, other autoimmune disorders, Cancer and HIV / Aids, you will not want to miss this informative event. As the public awareness and acceptance of LDN treatment grows, The 5th Annual Low Dose Naltrexone Conference promises to offer the latest insights of how use of the drug is challenging many medical assumptions of today.
Project LDN: Funding Clinical Trials is the conference theme this year and represents a call to action for all those interested in seeing LDN treatment advance as a mainstream protocol. The current agenda now includes presentations by Dr. Burt Berkson, Pharmacist Skip Lenz, and author Mary Boyle Bradley. Plenty of time will be allotted to answer attendee questions, meet with people who have in-depth experience with LDN treatment, as well as the open discussion of ideas on how to best fund future research and study of LDN.
The off-label protocol referred to as Low Dose Naltrexone (LDN) modulates the immune system and promotes healing. Relying on clinical trial results and interviews with the leading LDN researchers worldwide, we describe the history of LDN and explain its biochemical and molecular effects. In clinical trials, LDN has been shown to halt disease progression in Crohn’s disease and certain cancers, including pancreatic cancer, and to reduce symptoms in multiple sclerosis (MS) and autism. Ongoing trials are evaluating LDN in fibromyalgia and HIV/AIDS. Anecdotally, LDN has been shown to improve almost every autoimmune and neurodegenerative condition, including Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
DHLA Nano-Plex™, the world's first and only stable, live-source, reduced form of DHLA, is vastly superior to alpha-lipoic acid (ALA), R-lipoic acid or R-DHLA in long term DNA protection and free radical quenching capacity
IF ONLY ...
· .. you could get the best lipoic acid, the reduced form (DHLA), highly bio-available, ensuring enhanced metabolism,* ATP synthesis and the ultimate in free radical quenching. Then you'd get the very best benefits - especially for those running out of time. Now you can!
WE DID IT-
For the first time in history (patent pending), we have developed a stable, fully reduced form of lipoic acid (DHLA) - derived from "once-living" sources (not typical synthetic sources). Now you can get huge amounts of exquisitely bio-available DHLA, fully active and intracellularly potent. The lab director who performed the independent laboratory assay on our DHLA expressed his surprise at the creation of DHLA in a stable form - which has never been done before. 1
And It Really Works -
DHLA Nano-Plex™, the world's first and only stable, live-source, reduced form of DHLA, is vastly superior to alpha-lipoic acid (ALA), R-lipoic acid or R-DHLA in long term DNA protection and free radical quenching capacity - and thus can deliver more comprehensive reduction of oxidative stress for literally EVERY organ and gland, especially the brain and the nervous system.* For example, DHLA Nano-Plex™ can quench the superoxide anion free radical and the peroxyl radical whereas ALA and R-lipoic acid cannot.
How DID we do it?
In our proprietary process, DHLA Nano-Plex™ is produced by 12 strains of beneficial probiotic organisms that pre-culture and "nanize" our nutrient sources where they become part of the living probiotic structure, micro-digested into particle sizes so tiny they become exceptionally bio-available. Just 1/4 tsp. provides 80 mg. of DHLA2 and 5 mg of Resveratrol. Take note: there are NO OTHER live-source DHLAsupplements available in the world! The closest you might come is a product with alpha-lipoic, R-lipoic acid or R-DHLA (but from non-live sources).
Fast-Acting. Excellent for even your worst cases. Many people experience a sense of increased energy and well being with the very first dose. Start the DHLA immune system cleanup today. Available in 2 oz glass bottles; 48 servings/bottle.
DHLA is the only known antioxidant (notALAor R-lipoic acid) capable of quenching every known free radical found in living cells: all ROS (reactive oxygen species) and RNS (reactive nitrogen species). While ALA and R-lipoic acid forms may be helpful, they cannot compare with the free radical quenching power of DHLA, nor can they compare to the boost in metabolism and ATP synthesis of DHLA.
Most all sources of ALA, R-lipoic or R-DHLA are synthetic - devoid of a "body of light" and therefore, ultimately act to degrade cellular DNA and, with long-term use, they can accelerate aging (as shown in biophotonic research by Dr. Fritz-Albert Popp, a noted German biophysicist).
DHLA Nano-Plex™, on the other hand, is not only the superior, reduced form of lipoic acid (DHLA), but it is also derived from "onceliving" nutrient sources (not devitalized, synthetic sources) so a single serving has long-lasting benefits that no amount of synthetic alpha lipoic acid, R-lipoic and R-DHLA can deliver.
Experience for yourself the increased energy, mental clarity, concentration and sense of well-being - only
possible with "once-living" DHLA Nano-Plex™.*
Hi Lauranimal did you ever get all those fillings removed?
Lauranimal said:Aside from having six mercury fillings in my teeth, as a kid I had broken a thermometer. The mercury was the most fascinating thing I had ever seen! I kept it in a little gift box and took it out to play with every day for at least a week. putting it on a saucer, rolling it around, touching it with my fingers (and most certainly touching my face after that).
Never heard of it, perhaps she has some info or some reference?Gertrudes said:This week I was talking to a nutritionist and she told me that ALA actually feeds Candida. Anyone heard anything similar?
Psyche said:ALA is an exc chelator, and candida binds to heavy metals in the gut, so I was wondering if it was related to this. But in this case, it would not feed candida, it could make candida free in the gut, ready to get rid off by anti-fungal means.
Gertrudes said:Thanks Psyche.
I will email her and ask for some references. It will likely take a while for her to get back to me though
I doubt it’s a transient thing. It is the experience of many doctors involved in chelating heavy metals in autistic children. It has also been something I’ve observed on a couple of occasions. Many sulphur containing compounds used for chelation seem to also have the capacity to aggravate gut imbalances. Obviously it does depend on the state of your gut to begin with and your susceptibility to such problems too. You can just try it and see but it’s something to bear in mind if you do get an unexplained flare up of fungal/yeast symptoms.
Gertrudes said:Ok, I'm pasting what she has just e-mailed me:
I doubt it’s a transient thing. It is the experience of many doctors involved in chelating heavy metals in autistic children. It has also been something I’ve observed on a couple of occasions. Many sulphur containing compounds used for chelation seem to also have the capacity to aggravate gut imbalances. Obviously it does depend on the state of your gut to begin with and your susceptibility to such problems too. You can just try it and see but it’s something to bear in mind if you do get an unexplained flare up of fungal/yeast symptoms.
Any thoughts?
autism.com said:Some detoxification treatments can cause or exacerbate bacteria/yeast dysbiosis, either directly by providing food to them, or by causing excretion of toxic metals into the gut. This appears to especially be a problem for oral alpha lipoic acid and NAC, sometimes is a problem for oral DMSA, somewhat less of a problem for oral DMPS, and perhaps rarely a problem for transdermal DMPS.